ENGLEWOOD, Colo. In a remarkable stride towards innovation and financial robustness, Paragon 28, Inc. (NYSE: FNA), a leading medical device company dedicated to advancing foot and ankle orthopedic care, has announced the launch of the groundbreaking SMART28 Case Management Portal. This launch represents a significant milestone in the company’s ongoing SMART28 initiative, designed to revolutionize foot and ankle treatments through the application of artificial intelligence and state-of-the-art technology.
The SMART28 Case Management Portal is an avant-garde platform that leverages the power of AI to create a seamless and efficient user experience for coordinating patient-specific surgical plans. As the first major release within the SMART28 ecosystem, this pioneering portal aims to transform traditional surgical planning processes into a more streamlined, data-driven approach that enhances patient outcomes. Paragon 28’s commitment to utilizing AI underscores the company’s forward-thinking strategy in improving all facets of foot and ankle healthcare.
The launch of the SMART28 Case Management Portal is accompanied by the successful first case using the innovative SMART Bun-Yo-Matic, further exemplifying the portal’s potential in real-world applications. This initiative aligns with Paragon 28’s overarching goal to employ cutting-edge technologies to optimize patient care and treatment efficacy.
Concurrently, Paragon 28 has strengthened its financial position by securing a new $150 million credit facility from Ares Capital Corporation. This new facility, which effectively replaces the company’s existing $90 million senior credit facility, comprises up to $100 million in term loans with an initial draw of $75 million at closing and an additional $50 million revolving credit facility. The infusion of capital is expected to bolster Paragon 28’s capacity for innovation, enabling further investments in their SMART28 initiative and other strategic advancements.
The convergence of these developments a pivotal technological launch and reinforced financial stability positions Paragon 28 to continue its trajectory of growth and innovation in the specialized field of foot and ankle orthopedic care. Ultimately, these enhancements reflect the company’s unwavering dedication to pushing the envelope in medical technology and improving patient health outcomes.
Comments